POINT BIOPHARMA GLOBAL INC (PNT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:PNT • US7305411099

12.5 USD
+0.02 (+0.16%)
At close: Dec 26, 2023
12.51 USD
+0.01 (+0.08%)
After Hours: 12/26/2023, 8:10:43 PM
Fundamental Rating

5

Taking everything into account, PNT scores 5 out of 10 in our fundamental rating. PNT was compared to 525 industry peers in the Biotechnology industry. PNT has an excellent financial health rating, but there are some minor concerns on its profitability. PNT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • PNT had positive earnings in the past year.
  • In the past year PNT had a positive cash flow from operations.
PNT Yearly Net Income VS EBIT VS OCF VS FCFPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 50M -50M 100M 150M

1.2 Ratios

  • The Return On Assets of PNT (20.22%) is better than 99.49% of its industry peers.
  • PNT has a Return On Equity of 22.77%. This is amongst the best in the industry. PNT outperforms 97.81% of its industry peers.
  • PNT has a Return On Invested Capital of 18.63%. This is amongst the best in the industry. PNT outperforms 99.33% of its industry peers.
Industry RankSector Rank
ROA 20.22%
ROE 22.77%
ROIC 18.63%
ROA(3y)-20.26%
ROA(5y)N/A
ROE(3y)-32.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PNT Yearly ROA, ROE, ROICPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 20 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of PNT (39.62%) is better than 99.33% of its industry peers.
  • PNT's Operating Margin of 44.22% is amongst the best of the industry. PNT outperforms 98.99% of its industry peers.
Industry RankSector Rank
OM 44.22%
PM (TTM) 39.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PNT Yearly Profit, Operating, Gross MarginsPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PNT is creating some value.
  • Compared to 1 year ago, PNT has more shares outstanding
  • PNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PNT Yearly Shares OutstandingPNT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
PNT Yearly Total Debt VS Total AssetsPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 16.90 indicates that PNT is not in any danger for bankruptcy at the moment.
  • PNT has a better Altman-Z score (16.90) than 91.23% of its industry peers.
  • The Debt to FCF ratio of PNT is 0.06, which is an excellent value as it means it would take PNT, only 0.06 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.06, PNT belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
  • PNT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of PNT (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.06
Altman-Z 16.9
ROIC/WACC1.67
WACC11.15%
PNT Yearly LT Debt VS Equity VS FCFPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 9.13 indicates that PNT has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 9.13, PNT is doing good in the industry, outperforming 73.52% of the companies in the same industry.
  • A Quick Ratio of 9.13 indicates that PNT has no problem at all paying its short term obligations.
  • The Quick ratio of PNT (9.13) is better than 73.69% of its industry peers.
Industry RankSector Rank
Current Ratio 9.13
Quick Ratio 9.13
PNT Yearly Current Assets VS Current LiabilitesPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

  • PNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 195.40%, which is quite impressive.
EPS 1Y (TTM)195.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.54%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 22.94% on average over the next years. This is a very strong growth
  • PNT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.58% yearly.
EPS Next Y9.21%
EPS Next 2Y-2.62%
EPS Next 3Y36.93%
EPS Next 5Y22.94%
Revenue Next Year-14.35%
Revenue Next 2Y21.4%
Revenue Next 3Y112.36%
Revenue Next 5Y72.58%

3.3 Evolution

PNT Yearly Revenue VS EstimatesPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
PNT Yearly EPS VS EstimatesPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.06, PNT is valued correctly.
  • Based on the Price/Earnings ratio, PNT is valued cheaply inside the industry as 97.47% of the companies are valued more expensively.
  • PNT is valuated rather cheaply when we compare the Price/Earnings ratio to 28.30, which is the current average of the S&P500 Index.
  • The Forward Price/Earnings Ratio is negative for PNT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 15.06
Fwd PE N/A
PNT Price Earnings VS Forward Price EarningsPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • 97.98% of the companies in the same industry are more expensive than PNT, based on the Enterprise Value to EBITDA ratio.
  • 97.64% of the companies in the same industry are more expensive than PNT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.37
EV/EBITDA 6.16
PNT Per share dataPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • PNT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as PNT's earnings are expected to grow with 36.93% in the coming years.
PEG (NY)1.64
PEG (5Y)N/A
EPS Next 2Y-2.62%
EPS Next 3Y36.93%

0

5. Dividend

5.1 Amount

  • No dividends for PNT!.
Industry RankSector Rank
Dividend Yield N/A

POINT BIOPHARMA GLOBAL INC / PNT FAQ

What is the ChartMill fundamental rating of POINT BIOPHARMA GLOBAL INC (PNT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to PNT.


Can you provide the valuation status for POINT BIOPHARMA GLOBAL INC?

ChartMill assigns a valuation rating of 5 / 10 to POINT BIOPHARMA GLOBAL INC (PNT). This can be considered as Fairly Valued.


What is the profitability of PNT stock?

POINT BIOPHARMA GLOBAL INC (PNT) has a profitability rating of 4 / 10.


What is the financial health of POINT BIOPHARMA GLOBAL INC (PNT) stock?

The financial health rating of POINT BIOPHARMA GLOBAL INC (PNT) is 8 / 10.